Lisa A. Kachnic
Columbia University
289 Papers
2K Citations
Lisa A. Kachnic is an academic researcher from Columbia University. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 48, co-authored 251 publications. Previous affiliations of Lisa A. Kachnic include Dresden University of Technology & Emory University.
Chat about Author
Papers
•Journal Article
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
Christopher G. Willett,J. A. Ajani,D. P. Kelsen,Elin R. Sigurdson,Ross A. Abrams,B. Berkey,Benetz M,Christopher H. Crane,Laurie E. Gaspar,Goodyear,Leonard L. Gunderson,Michael G. Haddock,Hoffmann J,Nora A. Janjan,Madhu John,Lisa A. Kachnic,Richard Krieg,Jerome C. Landry,Neal J. Meropol,B.D. Minsky,Edith P. Mitchell,M. Mohiuddin,John E. Moulder,Robert J. Myerson,Dirk Noyes,Thomas F. Pajak,David Raben,William F. Regine,Tyvin A. Rich,John M. Robertson,Anthony H. Russell,John M. Skibber,Kim P +32 more
2
•Journal Article
Jury still out on whether advanced technology can improve the outcomes of patients with anal canal cancer.
Andre Konski,Lisa A. Kachnic +1 more
TL;DR: The authors well delineate, the treatment of anal canal cancer has progressed from radical surgery to organ preservation with the use of definitive chemoradiotherapy with the help of intensity-modulated radiation therapy.
2
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: Report of RTOG 0517.
Michael J. Seider,Stephanie Shook,Corey J. Langer,Gwen Wyatt,W. Demas,Afshin Rashtian,Cathy L. Clausen,Jerry Derdel,Sean F. Cleary,Christopher A. Peters,Ashok Ramalingam,James E. Clarkson,M. Tomblyn,Rachel Rabinovitch,Lisa A. Kachnic,Lawrence B. Berk +15 more
TL;DR: It is postulated that the radiopharmaceuticals, Strontium-89 (Sr89) and Samarium-153 (Sm153), when added to a bisphosphonate can decrease the incidence of SREs.
2
American board of radiology maintenance of certification program: Evolution to better serve stakeholders
Paul E. Wallner,Dennis C. Shrieve,Lisa A. Kachnic,Lynn D. Wilson,Stephen M. Hahn,Kaled M. Alektiar,David Laszakovits,Milton J. Guiberteau +7 more
TL;DR: This research presents a novel and scalable approach called “cell reprograming” that allows for real-time, 3D image analysis of the response of the immune system to chemotherapy treatment.
2